Overview
X-linked mixed deafness with perilymphatic gusher, also known as X-linked deafness type 3 (DFN3) or X-linked stapes gusher syndrome, is a rare genetic hearing disorder caused by mutations in the POU3F4 gene located on the X chromosome. The condition primarily affects the auditory system and is characterized by a distinctive combination of conductive and sensorineural hearing loss (mixed hearing loss). Males are predominantly affected, while carrier females may have mild or no hearing impairment. A hallmark feature of this condition is an abnormal communication between the cerebrospinal fluid spaces and the perilymphatic space of the inner ear, resulting from developmental abnormalities of the temporal bone, including dilation of the internal auditory canal and deficiency of the bony partition between the cochlear base and the internal auditory canal. The most clinically significant aspect of this disorder is the risk of a perilymphatic gusher — a sudden, forceful outpouring of perilymphatic fluid — during stapes surgery (stapedectomy or stapedotomy), which is sometimes attempted to correct the conductive component of hearing loss. This complication can lead to profound sensorineural hearing loss and is potentially dangerous. Temporal bone imaging typically reveals characteristic findings including bulbous dilation of the lateral end of the internal auditory canal, incomplete partition of the cochlea, and abnormal communication between the subarachnoid space and the inner ear. Hearing loss is typically congenital or presents in early childhood and is progressive. Management of this condition requires careful consideration. Stapes surgery is generally contraindicated due to the high risk of perilymphatic gusher and worsening of hearing. Hearing aids may provide benefit for some patients. Cochlear implantation has been successfully performed in affected individuals, though surgeons must be aware of the risk of cerebrospinal fluid leak during the procedure. Genetic counseling is important for affected families. Early identification through genetic testing and temporal bone CT imaging is crucial for appropriate management and surgical planning.
Also known as:
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for X-linked mixed deafness with perilymphatic gusher.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for X-linked mixed deafness with perilymphatic gusher at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for X-linked mixed deafness with perilymphatic gusher.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to X-linked mixed deafness with perilymphatic gusher.
Community
No community posts yet. Be the first to share your experience with X-linked mixed deafness with perilymphatic gusher.
Start the conversation →Latest news about X-linked mixed deafness with perilymphatic gusher
No recent news articles for X-linked mixed deafness with perilymphatic gusher.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about X-linked mixed deafness with perilymphatic gusher
What is X-linked mixed deafness with perilymphatic gusher?
X-linked mixed deafness with perilymphatic gusher, also known as X-linked deafness type 3 (DFN3) or X-linked stapes gusher syndrome, is a rare genetic hearing disorder caused by mutations in the POU3F4 gene located on the X chromosome. The condition primarily affects the auditory system and is characterized by a distinctive combination of conductive and sensorineural hearing loss (mixed hearing loss). Males are predominantly affected, while carrier females may have mild or no hearing impairment. A hallmark feature of this condition is an abnormal communication between the cerebrospinal fluid s
How is X-linked mixed deafness with perilymphatic gusher inherited?
X-linked mixed deafness with perilymphatic gusher follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does X-linked mixed deafness with perilymphatic gusher typically begin?
Typical onset of X-linked mixed deafness with perilymphatic gusher is childhood. Age of onset can vary across affected individuals.